We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Autofluorescence in Uveitic and Diabetic Macular Edema

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00956124
Recruitment Status : Withdrawn (Technical issue)
First Posted : August 11, 2009
Last Update Posted : April 25, 2017
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
The aim of this study is to determine whether fundus autofluorescence and macular pigment distribution in inflammatory and diabetic macular edema are altered.

Condition or disease
Uveitis Macular Edema

Detailed Description:
After macular pigment measuring we will perform fundus autofluorescence, fluorescein angiography and optical coherence tomography. any associations of macular pigment distribution and fundus autofluorescence with macular anatomic features are analyzed. primary outcome measure is the macular pigment distribution in patients with altered fundus autofluorescence. Furthermore we will compare the findings between diabetic and inflammatory edema.

Study Design

Study Type : Observational
Actual Enrollment : 0 participants
Observational Model: Case-Control
Time Perspective: Prospective
Study Start Date : October 2010
Primary Completion Date : October 2011
Study Completion Date : June 1, 2016

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Edema
U.S. FDA Resources

Groups and Cohorts

Group/Cohort
uveitic patients
patients with diabetes


Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
patients with uveitis or diabetes
Criteria

Inclusion Criteria:

  • patients with diabetic or uveitis macular edema

Exclusion Criteria:

  • children patients with known allergy to fluorescein
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00956124


Locations
Germany
Department of Ophthalmology at St Franziskus Hospital
Muenster, North-Rhine-Westfalia, Germany, 48145
Sponsors and Collaborators
St. Franziskus Hospital
More Information

Responsible Party: Carsten Heinz, Head of Department, St. Franziskus Hospital
ClinicalTrials.gov Identifier: NCT00956124     History of Changes
Other Study ID Numbers: 2009-017-f-S
First Posted: August 11, 2009    Key Record Dates
Last Update Posted: April 25, 2017
Last Verified: April 2017

Additional relevant MeSH terms:
Edema
Macular Edema
Uveitis
Signs and Symptoms
Macular Degeneration
Retinal Degeneration
Retinal Diseases
Eye Diseases
Uveal Diseases